Medication review and deprescribing in different healthcare settings: a position statement from an Italian scientific consortium.

"Declarations Conflict of interestGT has served in the last 3 years on advisory boards/seminars funded by Sanofi, Eli Lilly, AstraZeneca, Abbvie, Novo Nordisk, Gilead, and Amgen; he is also a scientific coordinator of the academic spin-off “INSPIRE srl”, which has received funding for conducting observational studies from several pharmaceutical companies. None of these listed activities is related to the topic of the article. The other authors have no competing interests to declare that are relevant to the content of this article. Human and animal rightsThis article does not contain any studies with human participants or animals performed by any authors. Ethical approvalNot applicable. Informed consentFor this type of study, formal consent is not required. Conflict of interest GT has served in the last 3 years on advisory boards/seminars funded by Sanofi, Eli Lilly, AstraZeneca, Abbvie, Novo Nordisk, Gilead, and Amgen; he is also a scientific coordinator of the academic spin-off “INSPIRE srl”, which has received funding for conducting observational studies from several pharmaceutical companies. None of these listed activities is related to the topic of the article. The other authors have no competing interests to declare that are relevant to the content of this article."

"Funding Open access funding provided by Università degli Studi di Verona within the CRUI-CARE Agreement. No funding was received for conducting this study."